Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 10 de 10
Filtrer
1.
Indian J Dermatol Venereol Leprol ; 87(6): 800-806, 2021.
Article de Anglais | MEDLINE | ID: mdl-34160163

RÉSUMÉ

BACKGROUND: The prevalence of dermatophytes varies with season, geographical area, socio-economic factors and effective management strategies. AIMS: The aim of the study was to assess the prevalence of pathogenic dermatophytes, clinical types of dermatophyte fungal infection, and in vitro antifungal drug susceptibility testing against dermatophytes. METHODS: Three hundred and ninety five patients with dermatophytosis were enrolled from five cities (Mumbai, Delhi, Lucknow, Kolkata and Hyderabad) across India. All patients were subjected to clinical examination and investigations, including potassium hydroxide microscopy, fungal culture and antifungal drug susceptibility testing. RESULTS: Trichophyton rubrum was the most common species identified (68.4%), followed by T. mentagrophytes (29.3%). Within species, T. mentagrophytes was prevalent in humid environmental conditions (Mumbai and Kolkata), whereas T. rubrum was prevalent in noncoastal areas (Delhi, Lucknow and Hyderabad). Tinea corporis (71.4%) and tinea cruris (62.0%) were the common clinical types observed. antifungal drug susceptibility testing data indicated that minimum inhibitory concentration required to inhibit the growth of 90% of organisms (MIC-90) was lowest for griseofulvin (0.25-3.0 µg/mL). Among oral antifungals, the mean MIC of itraconazole was within the range (0.84 [0.252] µg/ mL), whereas high mean MIC values were reported for terbinafine (0.05 [0.043] µg/mL). Among topical agents, lowest mean MIC values were reported for luliconazole (0.29 [0.286] µg/mL), eberconazole (0.32 [0.251]) µg/mL and amorolfine (0.60 [0.306]) µg/mL. LIMITATIONS: Lack of correlation between in vitro antifungal susceptibility and clinical outcome and absence of defined MIC breakpoints. CONCLUSION: T. rubrum was the most common, followed by T. mentagrophytes as an emerging/codominant fungal isolate in India. Tinea corporis was the most common clinical type of dermatophytosis. Mean MIC of terbinafine was above the reference range, while it was within the range for itraconazole; griseofulvin had the lowest mean MIC. Luliconazole presented the lowest mean MIC values across cities.


Sujet(s)
Antifongiques/pharmacologie , Teigne/microbiologie , Adolescent , Adulte , Études transversales , Femelle , Humains , Inde , Mâle , Tests de sensibilité microbienne , Adulte d'âge moyen , Teigne/traitement médicamenteux , Jeune adulte
2.
Int J Trichology ; 11(3): 101-106, 2019.
Article de Anglais | MEDLINE | ID: mdl-31360037

RÉSUMÉ

Androgenetic alopecia (AGA), also known as androgenic or pattern alopecia, is a frequently reported disorder that affects both the sexes, with a higher incidence generally reported in men. AGA has immense psychological effects on the patient, irrespective of the age or stage of baldness. This consensus document has been developed taking into account the opinions of leading experts in the field of dermatology. The objective of this article is to provide the dermatologists with an evidence-based platform for choosing efficacious and safe therapy for patients with AGA. This review articulately summarizes the key opinions of the experts on all aspects of treatment for the effective management of AGA.

3.
Int J Trichology ; 11(3): 107-112, 2019.
Article de Anglais | MEDLINE | ID: mdl-31360038

RÉSUMÉ

Alopecia, a frequently reported problem, severely impacts the quality of life of patients and is often associated with loss of confidence and low self-esteem. Several conditions such as telogen effluvium (TE), anagen effluvium, diffuse type of alopecia areata, female pattern hair loss, hair shaft abnormalities, loose anagen hair syndrome, and congenital atrichia or hypotrichosis are associated with hair loss. The actual prevalence rate of TE is not reported since most cases are subclinical in nature. Further, since women get more distressed by hair fall and promptly seek treatment, they tend to be over-represented. However, both genders can suffer from this condition if triggering factors are present. This consensus paper was developed by taking into account opinions of renowned experts in the field and is hoped to serve as an evidence-based platform for selecting efficacious and safe therapy for patients with TE. This review presents a synopsis of the key opinions of experts on all aspects of treatment and effective management of this condition.

4.
Clin Infect Dis ; 44(9): 1235-44, 2007 May 01.
Article de Anglais | MEDLINE | ID: mdl-17407045

RÉSUMÉ

BACKGROUND: Adherence to antiretroviral therapy (ART) and correlates of adherence and virologic suppression among human immunodeficiency virus (HIV)-infected persons receiving ART in private, outpatient clinics in India is unknown. METHODS: Between December 2004 and April 2005, persons receiving ART at 3 private clinics in Mumbai, India, were interviewed regarding HIV care and adherence to ART. Physicians also completed a survey for each participant. Quantitative HIV-1 RNA level was determined for 200 participants. RESULTS: Of 279 participants, 73% reported > or = 95% adherence to ART. Adherence was positively associated with age > or = 50 years (adjusted odds ratio [aOR], 3.90), presence of comorbid conditions (aOR, 1.92), medication self-efficacy (aOR, 4.01), absence of pain in the past month (aOR, 2.14), and support from family and friends (aOR, 2.57). Lack of reminders from family members to take medication (aOR, 0.27) was negatively associated with adherence. Of 200 participants, 127 (63.5%) had virologic suppression (RNA level, < 400 copies/mL). Independent correlates of suppression were a regimen containing > or = 3 ART drugs (aOR, 5.52), first ART regimen (aOR, 3.28), adherence to therapy > or = 95% (aOR, 5.70), female sex (aOR, 3.19), and a physical component score > or = 50 (aOR, 1.07). CONCLUSION: Self-reported adherence to ART in a sample of patients attending Mumbai's private clinics was relatively high. However, the fact that a detectable viral level was found in nearly 40% of patients suggests that second-line ART regimens, as well as an emphasis on adherence and appropriate ART regimens in India, is needed.


Sujet(s)
Établissements de soins ambulatoires , Antirétroviraux/usage thérapeutique , Infections à VIH/traitement médicamenteux , Infections à VIH/virologie , Établissements de santé privés à but lucratif , Observance par le patient , Adulte , Études transversales , Femelle , Humains , Inde , Mâle , Adulte d'âge moyen , Population urbaine , Charge virale
8.
Fontilles, Rev. leprol ; 16(3): f317-319, Sep.-Dic. 1987.
Article de Anglais | Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1225548

RÉSUMÉ

Los autores informan de 3 casos de superdosificación de DDS. Un caso desarrolló psicosis tóxica, pero los otros pacientes no tivieron efectos significativos a pesar de la alta dosis consumida.


Sujet(s)
Lèpre/traitement médicamenteux
9.
Fontilles, Rev. leprol ; 16(3): 321-324, Sep.-Dic. 1987.
Article de Anglais | Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1225549

RÉSUMÉ

The authors report two cases of 'H' in leprosyworkers. One case a male previously treated and declared cured by various specialists, with relapse or reactivation (?) after 10 years. Is leprosy curable? Should we use protective measures for our workers? It is high time that we this disease more seriously.


Sujet(s)
Lèpre/épidémiologie
10.
Indian J Lepr ; 59(3): 313-4, 1987.
Article de Anglais | MEDLINE | ID: mdl-3440850

RÉSUMÉ

The authors report 3 cases of temporary generalized lymphoadenopathy directly related to Lamprene (Clofazimine) consumption. It appears that this side effect has never been reported in the literature.


Sujet(s)
Clofazimine/effets indésirables , Lèpre/traitement médicamenteux , Maladies lymphatiques/induit chimiquement , Clofazimine/usage thérapeutique , Femelle , Humains , Mâle
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE